Shandong Guobang Pharmaceutical

Shandong Guobang Pharmaceutical is a China-based pharmaceutical manufacturing company and a core subsidiary of Guobang Pharmaceutical Group focused on commercial production of active pharmaceutical ingredients, veterinary APIs, and key pharmaceutical intermediates. The company operates large-scale manufacturing in Weifang, Shandong, and emphasizes process chemistry, industrial scale-up, and integrated production capabilities across multiple chemical reaction types. Its disclosed product portfolio includes florfenicol, doxycycline hyclate, cyromazine, potassium borohydride, sodium borohydride, sodium hydride, cyclopropylamine, N-methylpiperazine, N-ethylpiperazine, and trimethyl borate. The business appears to be oriented toward global supply of established small-molecule products rather than development of a novel clinical pipeline. It serves pharmaceutical and animal health markets in China and internationally, including the US and Europe.